Group One Trading’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,625
| Closed | -$34.4K | – | 8111 |
|
|
2023
Q4 | $34.4K | Hold |
4,625
| – | – | ﹤0.01% | 5341 |
|
|
2023
Q3 | $44.8K | Hold |
4,625
| – | – | ﹤0.01% | 5201 |
|
|
2023
Q2 | $47.4K | Hold |
4,625
| – | – | ﹤0.01% | 5322 |
|
|
2023
Q1 | $48.3K | Sell |
4,625
-5,300
| -53% | -$70.5K | ﹤0.01% | 4876 |
|
|
2022
Q4 | $127K | Hold |
9,925
| – | – | ﹤0.01% | 4223 |
|
|
2022
Q3 | $155K | Buy |
9,925
+9,178
| +1,229% | +$176K | ﹤0.01% | 4380 |
|
|
2022
Q2 | $15K | Sell |
747
-219
| -23% | -$5.48K | ﹤0.01% | 6526 |
|
|
2022
Q1 | $35K | Sell |
966
-2,689
| -74% | -$96.7K | ﹤0.01% | 6380 |
|
|
2021
Q4 | $130K | Buy |
3,655
+384
| +12% | +$20.2K | ﹤0.01% | 5496 |
|
|
2021
Q3 | $245K | Sell |
3,271
-3,498
| -52% | -$248K | ﹤0.01% | 4957 |
|
|
2021
Q2 | $594K | Sell |
6,769
-394
| -6% | -$37.5K | ﹤0.01% | 4028 |
|
|
2021
Q1 | $817K | Buy |
7,163
+7,068
| +7,440% | +$784K | ﹤0.01% | 3481 |
|
|
2020
Q4 | $4K | Sell |
95
-9
| -9% | -$333 | ﹤0.01% | 6124 |
|
|
2020
Q3 | $4K | Buy |
104
+12
| +13% | +$532 | ﹤0.01% | 5702 |
|
|
2020
Q2 | $7K | Sell |
92
-8
| -8% | -$732 | ﹤0.01% | 5278 |
|
|
2020
Q1 | $5K | Sell |
100
-7
| -7% | -$638 | ﹤0.01% | 4799 |
|
|
2019
Q4 | $10K | Sell |
107
-164
| -61% | -$15.3K | ﹤0.01% | 4610 |
|
|
2019
Q3 | $28K | Sell |
271
-2,837
| -91% | -$614K | ﹤0.01% | 4233 |
|
|
2019
Q2 | $917K | Buy |
3,108
+2,548
| +455% | +$898K | 0.01% | 1659 |
|
|
2019
Q1 | $260K | Buy |
560
+398
| +246% | +$155K | ﹤0.01% | 2506 |
|
|
2018
Q4 | $48K | Buy |
162
+103
| +175% | +$24.6K | ﹤0.01% | 3588 |
|
|
2018
Q3 | $10K | Sell |
59
-38
| -39% | -$6.97K | ﹤0.01% | 4658 |
|
|
2018
Q2 | $19K | Buy |
97
+14
| +17% | +$2.58K | ﹤0.01% | 4389 |
|
|
2018
Q1 | $12K | Sell |
83
-41
| -33% | -$8.03K | ﹤0.01% | 4269 |
|
|
2017
Q4 | $30K | Buy |
124
+41
| +49% | +$8.54K | ﹤0.01% | 3991 |
|
|
2017
Q3 | $17K | Sell |
83
-34
| -29% | -$6.26K | ﹤0.01% | 4133 |
|
|
2017
Q2 | $12K | Sell |
117
-1,091
| -90% | -$173K | ﹤0.01% | 4146 |
|
|
2017
Q1 | $362K | Buy |
1,208
+884
| +273% | +$260K | ﹤0.01% | 2091 |
|
|
2016
Q4 | $117K | Buy |
+324
| New | +$121K | ﹤0.01% | 2752 |
|
Other funds holding CSCI
Group One Trading's CSCI Position: Q3 2025 in Review
Group One Trading sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 37 shares — an estimated $125 sold.
Group One Trading first reported a position in CSCI in Q2 2016 and held it in 21 quarters. The position peaked at $272K in Q3 2016. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.
- Group One Trading reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
- Group One Trading sold 37 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $125.
- Group One Trading first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2016 and held it in 21 quarters.
- Group One Trading's COSCIENS Biopharma Inc. Common Stock position peaked at $272K in Q3 2016.
- 2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.
Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.